A future partnership paper on Collaboration on Science and Innovation
has been published today by the Department for Exiting the European Union.
The Biochemical Society welcomes this paper, which outlines the UK’s objectives for an ambitious science and innovation agreement with the EU and invites discussion with the EU on how best to shape our future partnership in this area.
Commenting on the paper, Dr David Pye, Honorary Policy Officer of the Biochemical Society, said:
“We are pleased to see such a positive first step for the government in safeguarding the UK's leading position in science and innovation. The UK has benefited significantly from EU science funding programmes such as Horizon 2020, both in terms of the funding we have received as well as the excellent research and international collaboration which this has stimulated.
Today’s paper recognises the value of the research community's work and the need to maintain collaboration with our European partners on major science, research, and technology initiatives after leaving the EU, including continuing to work closely with the European Medicines Agency (EMA).
We look forward to seeing this commitment develop into specific actions and to working with the Government and other partners to ensure the UK continues to maintain its world-leading role in life sciences.”